InvestorsHub Logo
Followers 129
Posts 23648
Boards Moderated 1
Alias Born 09/14/2016

Re: None

Thursday, 03/14/2019 12:51:49 PM

Thursday, March 14, 2019 12:51:49 PM

Post# of 1294
$BIXT Bioxytran, Inc. is working to develop new molecules that address unmet medical needs. Bioxytran, Inc.’s drug candidates have a large market potential as anti-necrotic drugs for multiple disease indications that result from hypoxia.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BIXT News